Pregabalin – Uses, Mechanism & Side Effects
Pregabalin is a prescription medication used to treat nerve pain, epilepsy, and generalized anxiety disorder. It works by calming overactive nerve signals in the brain and spinal cord.
Wissenswertes über "Pregabalin"
Pregabalin is a prescription medication used to treat nerve pain, epilepsy, and generalized anxiety disorder. It works by calming overactive nerve signals in the brain and spinal cord.
What is Pregabalin?
Pregabalin is a prescription-only medication belonging to the class of anticonvulsants and analgesics. It is structurally related to the neurotransmitter gamma-aminobutyric acid (GABA), but does not bind to GABA receptors. Instead, it acts on specific calcium channels in the nervous system. Pregabalin is marketed under the brand name Lyrica and has been approved by the European Medicines Agency (EMA) since 2004. Generic versions are also widely available.
Indications
Pregabalin is approved and clinically used for the following conditions:
- Neuropathic pain: Nerve pain caused by diabetes (diabetic peripheral neuropathy), shingles (postherpetic neuralgia), and central pain syndromes associated with spinal cord injury or multiple sclerosis.
- Epilepsy: As adjunctive therapy for focal (partial) seizures with or without secondary generalization in adults.
- Generalized Anxiety Disorder (GAD): For the treatment of persistent, excessive worry and anxiety in adults.
- Fibromyalgia: Approved in some countries, including the United States; used off-label in others.
Mechanism of Action
Pregabalin selectively binds to the alpha-2-delta subunit of voltage-gated calcium channels in hyperexcitable neurons. This binding reduces the release of excitatory neurotransmitters such as glutamate, norepinephrine, and substance P. As a result, abnormal electrical activity in nerve cells is dampened, leading to a reduction in pain signals and a suppression of epileptic seizures. Despite its structural similarity to GABA, pregabalin does not act directly on GABA receptors.
Dosage and Administration
Dosage is determined individually by the prescribing physician and depends on the indication and the renal function of the patient. General guidelines are:
- Neuropathic pain: 150–600 mg per day, divided into 2–3 doses.
- Epilepsy: 150–600 mg per day, divided into 2–3 doses.
- Generalized Anxiety Disorder: 150–600 mg per day, divided into 2–3 doses.
Treatment is typically initiated at a low dose, which is gradually increased. Pregabalin can be taken with or without food. In patients with impaired kidney function, dose adjustment is necessary, as pregabalin is primarily excreted via the kidneys.
Side Effects
Pregabalin may cause a range of side effects. The most common include:
- Very common (more than 1 in 10 patients): Dizziness, drowsiness (somnolence), headache.
- Common (1 in 10–100 patients): Weight gain, mood changes, blurred vision, dry mouth, peripheral edema (fluid retention), memory and concentration difficulties.
- Uncommon: Changes in heart rate, sexual dysfunction, muscle twitching.
Abrupt discontinuation of pregabalin can lead to withdrawal symptoms including insomnia, nausea, headache, and anxiety. The dose should always be tapered gradually under medical supervision.
Dependence Potential and Misuse
Pregabalin carries a recognized risk of dependence and misuse, particularly in individuals with a history of substance use disorders. In Germany, pregabalin was reclassified as a controlled substance under the Narcotics Prescription Ordinance (BtMVV) in 2019, requiring stricter prescribing protocols. Regular medical monitoring is essential during long-term use.
Contraindications and Drug Interactions
Pregabalin should not be used in cases of:
- Known hypersensitivity to pregabalin or any of its excipients.
- Pregnancy and breastfeeding (only after careful benefit-risk assessment).
Clinically significant interactions exist with:
- Alcohol and other central nervous system depressants (enhanced sedation).
- Opioid analgesics (increased risk of respiratory depression).
- Benzodiazepines (enhanced sedation and increased risk of dependence).
References
- European Medicines Agency (EMA): Lyrica – Summary of Product Characteristics. EMA, 2023. Available at: https://www.ema.europa.eu
- Dworkin RH et al.: Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Archives of Neurology, 2003; 60(11):1524–1534. PubMed PMID: 14623723.
- Frampton JE: Pregabalin: A Review of its Use in Adults with Generalized Anxiety Disorder. CNS Drugs, 2014; 28(9):835–854. PubMed PMID: 25149863.
Best-selling products
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryExtrauterine
Irritable Bowel Syndrome Prevention Program
Inflammatory Cytokine Analysis
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Pregabalin + Pregabalinum